← Leaderboards
Heather Durham
Nexgenix Pharmaceuticals, Inc.
$160,000
Attributed
$320,000
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $177.7K · FY2010–11$200K$150K$100K$50K$0
'10
'11
Funding mix
By agency
NIH$320,000 · 1
By mechanism
R21$320,000 · 1
Top collaborators
- Ruihong Chen2 shared
Most similar at Nexgenix Pharmaceuticals, Inc.
Same institution · by research overlap
- Ruihong Chen$277,482
Others in their field
Top investigators on “Adult”
- Lawrence Corey · Fred Hutchinson Cancer Center$594,628,824
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$397,114,680
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$388,038,550
- Judith S. Currier · University Of California Los Angeles$251,592,913
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$196,603,707
- Carol Nesel · Westat$188,148,170
Research focus
AdultAmyotrophic Lateral SclerosisAnimal ModelBaseBinding (Molecular Function)Blood - Brain Barrier AnatomyBrainCellsCessation Of LifeClientComplexCuprozinc Superoxide DismutaseDiagnosisDisease ProgressionDosageDoseDrug DevelopmentDrug KineticsEffectivenessEmbryoEpigenetic ProcessExperimental ModelsFamilial Amyotrophic Lateral SclerosisAdopted